2018 American Transplant Congress
Provision of Highly Specialized Aftercare by the Transplant Center Strongly Improves Patient, Pancreas and Kidney Allograft Survival in Long-Term Follow-Up after Simultaneous Pancreas-Kidney Transplantation
Despite rapid medical advancements in the field of transplantation, mean allograft survival remained at a standstill. If and to what extent a highly specialized and…2018 American Transplant Congress
Evolutive Analysis of a 20-Year Pancreas Transplant Program
There is a worldwide trend towards a reduction in the annual number of pancreas transplants (PT). In Brazil, only two centers have performed more than…2018 American Transplant Congress
Experience with Alemtuzumab Induction with Tacrolimus/Mycophenolate +/- Steroids in Simultaneous Pancreas-Kidney Transplant Recipients with Portal-Enteric Drainage
Surgery, Medicine, Pathology, Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC.
Introduction: Simultaneous pancreas-kidney transplant (SPKT) recipients are a relatively homogeneous population that are considered high immunological risk because of younger age, presumed autoimmune etiology of…2018 American Transplant Congress
Rejection and Graft Loss in Patients with BK Viremia after Simultaneous Pancreas and Kidney Transplant
University of Minnesota, Minneapolis, MN.
Background: BK virus is a recognized cause of kidney allograft dysfunction. The treatment of BK is immunosuppression reduction. This reduction in patients with a simultaneous…2018 American Transplant Congress
BK Viremia in Simultaneous Kidney Pancreas Recipients: Single Center Experience
Introduction: The impact of BK viremia in recipients of simultaneous pancreas and kidney transplantation (SPK) is not well known. We therefore studied the incidence and…2018 American Transplant Congress
Impact of New Pancreas Transplant Allocation Policy on Pancreas Transplant Volume and Outcomes: A Single Center Study
BACKGROUND: A UNOS/OPTN policy approved in 2015 allowed simultaneous pancreas-kidney transplants (SPK) for type-2 diabetic patients. We examined the effect of this policy on volume…2018 American Transplant Congress
Analyzing Transplant Medication Myths
Division of Transplant, Virginia Mason Medical Center, Seattle, WA.
Patients may misconstrue the amount of medications required for transplantation, expecting to take “handfuls” of medications for life. This study aims to determine the change…2017 American Transplant Congress
Survival Benefit of Kidney and/or Pancreas Transplantation for Patients with Type 1 Diabetes in the United States.
Study Purpose: The purpose of this study was to determine the survival benefit of pancreas and/or kidney transplants as reported over a 28-year time period…2017 American Transplant Congress
Simultaneous Pancreas and Kidney Transplant (SPK) – The New Standard of Care for Uremic Patients with Type 2 Diabetes Mellitus (T2DM).
Surgery, SUNY Upstate Medical University, Syracuse, NY
Introduction: While a SPK is now considered standard of care for uremic T1 DM patients, it is not for T2DM (despite similar medical issues). The…2017 American Transplant Congress
Utility of Concomitant Biopsy in Simultaneous Pancreas Kidney Transplant Recipients in the Identification of Rejection of Pancreas and Kidney.
Mayo Clinic Arizona, Phoenix, AZ
Background: In simultaneous pancreas and kidney transplant (SPKTx) recipients, animal studies suggest concordant rejection rates of 88% (ref: Gruessner et al,1994). Limited information is available…
- « Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 16
- Next Page »